Expression of insulin-like growth factor-1 receptor (IGF-1R) as a marker of response to erlotinib in pancreatic ductal adenocarcinoma (PDA)

Authors

C Solomides

Publication/Presentation Date

5-2001

Volume

29

Issue

15

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

Department(s)

Administration and Leadership

Document Type

Article

Share

COinS